Armstrong Pharmaceuticals Inc
Pharmaceutical ManufacturingMassachusetts, United States51-200 Employees
Armstrong Pharmaceuticals Inc is a pharmaceuticals company based out of 25 John Rd, Canton, MA, United States.
Growing Revenue Potential With an annual revenue estimated between 25 and 50 million dollars, Armstrong Pharmaceuticals presents a significant opportunity for partnership and supply chain collaborations within the pharmaceutical manufacturing sector.
Niche Market Position As a mid-sized company with 51 to 200 employees, Armstrong can be targeted for personalized, high-touch sales strategies, especially in areas requiring specialized pharmaceutical production or innovative formulations.
Technology Adoption Opportunities Although specific recent technological initiatives are not detailed, leveraging advancements in manufacturing technology or digital transformation could enhance Armstrong's production efficiency and quality control, presenting upsell or partnership avenues.
Market Expansion Potential Positioned amidst industry giants like Pfizer and Johnson & Johnson, Armstrong can seek strategic partnerships or supply agreements with suppliers, distributors, or research organizations to expand its market reach.
Industry Trends Alignment Given the ongoing emphasis on innovative and sustainable pharmaceutical manufacturing, engaging Armstrong in initiatives related to sustainability, compliance, or new drug development could open new sales channels and collaborative opportunities.
| Armstrong Pharmaceuticals Inc Email Formats | Percentage |
| FirstL@armstrong-pharma.com | 71% |
| First.Last@armstrong-pharma.com | 12% |
| FLast@armstrong-pharma.com | 9% |
| LFirst@armstrong-pharma.com | 8% |
Pharmaceutical ManufacturingMassachusetts, United States51-200 Employees
Armstrong Pharmaceuticals Inc is a pharmaceuticals company based out of 25 John Rd, Canton, MA, United States.
Armstrong Pharmaceuticals Inc's revenue is estimated to be in the range of $25M$50M
Armstrong Pharmaceuticals Inc's revenue is estimated to be in the range of $25M$50M